Third quarter performance update
Blis Technologies Limited: Ground Floor, 442 Moray Place, Dunedin Central 9016, PO Box 2208, Dunedin 9044, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
11 February 2022
Third quarter performance update
Blis Technologies Limited announces the interim results (unaudited) for the third quarter ending 31
December 2021.
Revenue for Q3 FY22
1
was $2.3m, with an EBITDA loss of $0.4m. Q3 FY22 revenue was down $0.1m
compared with the same period last year but has increased $0.2m over Q2 FY22
2
. The trends evident
in the half year result were also reflected in the third quarter result.
Compared with the same quarter last year, there was a 42% increase in finished product sales with
growth in our BLIS webstore (which includes Skincare sales) and the launch into the Canadian
market, which partially offset a decline in ingredient sales.
The Q3 FY22 EBITDA loss of $0.4m is in line with forecast and reflects further early investment in our
key new market initiatives, the Canada and Skincare launches which represent important future
growth drivers.
We reaffirm our existing market guidance of revenue between $8.6m and $9.1m with an EBITDA
deficit in the range of $2.3m to $2.7m.
1
The three months ended 31 December 2021
2
The three months ended 30 September 2021
Ends
For further information, please contact:
Brian Watson
CEO
+64 27 705 9133
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining
innovation with evidence-based research and the highest quality production controls enables the delivery
of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune
support, teeth and gum health and skin health. BLIS products are sold throughout New Zealand and in
Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at
www.blis.co.nz.
Website: www.blis.co.nz www.unconditionalskin.com
Instagram: @blisprobiotics @unconditionalskin #blisq24
Facebook: @BLISProbioticsNZ @unconditionalskin
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- BGP — Briscoe Group Limited: Full Year Results Announcement2022-03-15
“Results announcement Results for announcement to the market Name of issuer BRISCOE GROUP LIMITED Reporting Period Full Year (52 weeks) – 1 February 2021 to 30 January 2022 Previous Reporting Period Full Year (53 weeks) – 27 January 2020 to 31 January 2021 Currency…”
- THL — Tourism Holdings Limited: Market Update2021-12-10
“Tourism Holdings Limited Tel: +64 9 336 4299 The Beach House Fax: +64 9 309 9269 Level 1, 83 Beach Road www.thlonline.com Auckland City PO Box 4293, Shortland Street Auckland 1140, New Zealand Self drive Experiences New Zealand Australia USA UK Desig…”
- PEB — Pacific Edge Limited: Pacific Edge Results for Six Months Ended 30 September 20212021-11-24
“US GROWTH DRIVERS •Strong growth in revenue and cash receipts expected from CMS and Kaiser Permanente once Covid-19 restrictions ease •Scaled up commercial operations with 30 sales reps covering 21 sales territories will be operating by end- November 2021 (up from 22 as at 3…”